MENU
+Compare
BHVN
Stock ticker: NYSE
AS OF
Feb 21 closing price
Price
$36.91
Change
-$2.86 (-7.19%)
Capitalization
3.73B

BHVN Biohaven Ltd Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical drugs

Industry Biotechnology
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BHVN with price predictions
Feb 21, 2025

BHVN in downward trend: price dove below 50-day moving average on February 21, 2025

BHVN moved below its 50-day moving average on February 21, 2025 date and that indicates a change from an upward trend to a downward trend. In of 28 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BHVN as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BHVN turned negative on February 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 50-day moving average for BHVN moved below the 200-day moving average on January 28, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHVN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BHVN broke above its upper Bollinger Band on February 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for BHVN crossed bullishly above the 50-day moving average on February 12, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 302 cases where BHVN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.806) is normal, around the industry mean (12.481). P/E Ratio (0.000) is within average values for comparable stocks, (84.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). BHVN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (251.221).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BHVN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BHVN is expected to report earnings to fall 8.05% to -160 cents per share on March 20

Biohaven Ltd BHVN Stock Earnings Reports
Q4'24
Est.
$-1.60
Q3'24
Missed
by $0.04
Q2'24
Missed
by $1.72
Q1'24
Missed
by $0.65
Q4'23
Missed
by $0.40
The last earnings report on November 12 showed earnings per share of -174 cents, missing the estimate of -170 cents. With 836.32K shares outstanding, the current market capitalization sits at 3.73B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABCAX21.62-0.09
-0.41%
American Beacon The London Co Inc Eq A
GTMIX15.06-0.08
-0.53%
GMO International Opportunistic Val III
TOVIX15.77-0.10
-0.63%
American Beacon EAM Int Small Cap R5
BALFX35.29-0.35
-0.98%
American Funds American Balanced F1
AFDGX53.46-1.05
-1.93%
American Century Large Cap Equity R5

BHVN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
-7.19%
VCYT - BHVN
43%
Loosely correlated
-4.56%
APGE - BHVN
39%
Loosely correlated
+1.77%
ACLX - BHVN
38%
Loosely correlated
-2.83%
ABSI - BHVN
37%
Loosely correlated
-4.43%
OCUL - BHVN
36%
Loosely correlated
-3.45%
More